Medtronic Historical Cash Flow
| MDT Stock | USD 85.75 0.46 0.53% |
Analysis of Medtronic PLC cash flow over time is an excellent tool to project Medtronic PLC future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 1.1 B or Dividends Paid of 3.8 B as it is a great indicator of Medtronic PLC ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Medtronic PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medtronic PLC is a good buy for the upcoming year.
Medtronic |
About Medtronic Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Medtronic balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medtronic's non-liquid assets can be easily converted into cash.
Medtronic PLC Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Medtronic PLC value has been used up. For tax purposes Medtronic PLC can deduct the cost of the tangible assets it purchases as business expenses. However, Medtronic PLC must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Medtronic PLC to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Medtronic PLC operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Medtronic PLC financial statement analysis. It represents the amount of money remaining after all of Medtronic PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Medtronic PLC's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Exchange Rate Changes is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 419.9 M in 2024, despite the fact that Change In Cash is likely to grow to (246.1 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 1.4B | 1.5B | 1.6B | 1.7B | Dividends Paid | 3.4B | 3.6B | 3.7B | 3.8B |
Medtronic PLC cash flow statement Correlations
Click cells to compare fundamentals
Medtronic PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medtronic PLC cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (1.3B) | (652M) | (2.5B) | (645M) | (2.1B) | (2.0B) | |
| Change To Inventory | (577M) | 78M | (560M) | (939M) | (139M) | (146.0M) | |
| Change In Cash | (253M) | (547M) | 121M | (2.2B) | (259M) | (246.1M) | |
| Free Cash Flow | 6.0B | 4.9B | 6.0B | 4.6B | 5.2B | 2.8B | |
| Change In Working Capital | 61M | (701M) | (889M) | (967M) | (484M) | (459.8M) | |
| Begin Period Cash Flow | 4.4B | 4.1B | 3.6B | 3.7B | 1.5B | 1.7B | |
| Other Cashflows From Financing Activities | 5.5B | 9.7B | 163M | 7.3B | (3M) | (2.9M) | |
| Depreciation | 2.7B | 2.7B | 2.7B | 2.7B | 2.6B | 2.8B | |
| Other Non Cash Items | 722M | 687M | 711M | 396M | 1.1B | 1.1B | |
| Dividends Paid | 2.9B | 3.1B | 3.4B | 3.6B | 3.7B | 3.8B | |
| Capital Expenditures | 1.2B | 1.4B | 1.4B | 1.5B | 1.6B | 1.7B | |
| Total Cash From Operating Activities | 7.2B | 6.2B | 7.3B | 6.0B | 6.8B | 3.5B | |
| Net Income | 4.8B | 3.6B | 5.1B | 3.8B | 3.7B | 2.4B | |
| Total Cash From Financing Activities | (4.2B) | (4.1B) | (5.3B) | (5.0B) | (4.5B) | (4.2B) | |
| End Period Cash Flow | 4.1B | 3.6B | 3.7B | 1.5B | 1.3B | 1.8B | |
| Change To Liabilities | (44M) | 531M | 213M | 696M | 800.4M | 840.4M | |
| Other Cashflows From Investing Activities | (525M) | (54M) | (10M) | (1.9B) | (1.7B) | (1.6B) | |
| Change To Account Receivables | 1.3B | (761M) | (477M) | (576M) | (391M) | (371.5M) | |
| Total Cashflows From Investing Activities | (3.2B) | (2.9B) | (1.7B) | (3.5B) | (4.0B) | (4.2B) | |
| Change To Operating Activities | (624M) | (609M) | (549M) | (65M) | (58.5M) | (61.4M) | |
| Investments | (1.5B) | (463M) | (190M) | (3.5B) | (2.4B) | (2.2B) | |
| Net Borrowings | (713M) | (559M) | (570M) | (598M) | (538.2M) | (565.1M) | |
| Change To Netincome | (296M) | 633M | 489M | 525M | 603.8M | 633.9M | |
| Change Receivables | 1.3B | (761M) | (477M) | (576M) | (518.4M) | (492.5M) | |
| Cash And Cash Equivalents Changes | (167M) | (762M) | 351M | (2.4B) | (2.2B) | (2.1B) | |
| Cash Flows Other Operating | (609M) | (549M) | (65M) | (148M) | (133.2M) | (126.5M) | |
| Issuance Of Capital Stock | 662M | 474M | 429M | 308M | 284M | 419.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.